Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cystic fibrosis infection study halted early

NCT ID NCT03312075

Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aimed to find out how common non-tuberculous mycobacteria (NTM) infections are in people with cystic fibrosis in France. Researchers collected sputum and blood samples from 848 participants to test for NTM using culture and a new blood test. The study was terminated early, so results may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

848 people

The number who actually took part.

Started

Mar 2019

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Cystic fibrosis patients

Ages

7 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a confirmed diagnosis of cystic fibrosis regardless of CFTR genotype * Affiliation to the social security system * Patients able to expectorate spontaneously * Patients enrolled in the French Register of Cystic Fibrosis * Minor or major patients of expectorant age * Consent signed by the patient or the holder of parental authority for the children Exclusion Criteria: * Patient not registered in the French Register of Cystic Fibrosis * Pulmonary transplant patients * Persons deprived of liberty, persons under guardianship or curatorship, persons in emergency situations * Person not affiliated to a social security system or not entitled

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cystic fibrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cystic fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cystic fibrosis

Contacts and locations

Locations

  • AP-HP Hôpital Cochin

    Paris, 75679, France

  • AP-HP Hôpital Foch

    Suresnes, 92151, France

  • CHIC Créteil

    Créteil, 94000, France

  • CHR Sud Réunion

    Saint-Pierre, 97410, France

  • CHRU Brest

    Brest, 29200, France

  • CHU Amiens

    Amiens, Amiens, 80054, France

  • CHU Bordeaux

    Pessac, 33604, France

  • CHU Côte de Nacre

    Caen, 14033, France

  • CHU Grenoble

    Grenoble, 38043, France

  • CHU Lille

    Lille, 59037, France

  • CHU Rouen

    Rouen, 76031, France

  • CHU Toulouse

    Toulouse, 31059, France

  • CHU Tours

    Tours, 37044, France

  • Centre de Perharidy

    Roscoff, 29684, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.